FIELD: medicine; ophthalmology.
SUBSTANCE: group of inventions relates to the field of medicine, namely to ophthalmology; it is intended for prevention or treatment of degenerative processes of the macula. An eye drop composition in the form of a solution contains (2R, 3R, 4S)-6-amino-4-[N-(4-chlorophenyl)-N-(1H-imidazole-2-ylmethyl)amino]-3-hydroxy-2-methyl-2-dimethoxymethyl-3,4-dihydro-2H-1-benzopyran or its pharmaceutically acceptable salt, propylene glycol as a stabilizing agent, and a pH-regulating agent in an aqueous medium. The specified components are used in the claimed amounts. The eye drop composition has pH in the range from 4.0 to 5.0. A pharmaceutical product for the prevention or treatment of degenerative processes of the macula is also presented, obtained by placement of the specified eye drop composition to a light-impermeable container.
EFFECT: use of the group of inventions allows for an increase in the stability of an eye drop composition.
14 cl, 2 dwg, 17 tbl, 13 ex
Title | Year | Author | Number |
---|---|---|---|
PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT MACULAR DEGENERATION | 2012 |
|
RU2576380C2 |
METHOD OF PURIFYING A BENZOPYRAN DERIVATIVE, ITS CRYSTALLINE FORM AND A METHOD OF PRODUCING A CRYSTALLINE FORM | 2016 |
|
RU2729074C2 |
DERIVATIVES OF BENZOPYRANE SUBSTITUTED WITH SECONDARY AMINES COMPRISING TETRAZOLE, METHOD FOR THEIR PREPARING AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEREOF | 2003 |
|
RU2283312C2 |
STABLE COMPOSITION INCLUDING EPIDERMIC GROWTH FACTOR (EGF) AS ACTIVE INGREDIENT | 2001 |
|
RU2222344C2 |
PHARMACEUTICAL COMPOSITIONS CONTAINING BISPHOSPHONATE DERIVATIVES AND HIGH DOSES OF CHOLECALCIFEROL | 2010 |
|
RU2533230C2 |
OPHTHALMIC DROPS COMPOSITION | 2012 |
|
RU2623066C2 |
OPHTHALMIC FORMULATIONS FOR DRUG DELIVERY TO THE POSTERIOR SEGMENT OF THE EYE | 2014 |
|
RU2768489C2 |
LIQUID COMPOSITION OF LONG-ACTING INSULIN AND INSULINOTROPIC PEPTIDE | 2013 |
|
RU2643766C2 |
OCULAR COMPOSITIONS FOR DRUG-DELIVERY TO POSTERIOR SEGMENT OF THE EYE | 2014 |
|
RU2665953C2 |
OPHTHALMIC COMPOSITION CONTAINING CYCLOSPORINE AND TREHALOSE | 2015 |
|
RU2700927C2 |
Authors
Dates
2022-08-22—Published
2019-02-18—Filed